Submission date
06/04/2000
Registration date
06/04/2000
Last edited
04/10/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Retrospectively registered
? Protocol not yet added
? SAP not yet added
Results added
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Dr PJ Darbyshire

ORCID ID

Contact details

The Children's Hospital
Ladywood Middleway
Birmingham
B16 8ET
United Kingdom

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

G8223452

Study information

Scientific title

Acronym

UKALL R2

Study hypothesis

To compare continuing chemotherapy with unrelated donor BMT in relapsed childhood ALL following a common re-induction and consolidation regimen.

Ethics approval(s)

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Study setting(s)

Hospital

Study type

Not Specified

Patient information sheet

Condition

Acute Lymphoblastic Leukaemia

Intervention

Continuing chemotherapy/unrelated donor BMT

Intervention type

Other

Primary outcome measure

Survival, disease free survival

Secondary outcome measures

Not provided at time of registration

Overall study start date

01/02/1995

Overall study end date

30/09/2008

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

They are children under 15 years at original diagnosis and treated on UKALL trials or pilot studies with first relapse less than 4 years from the start of treatment of ALL at any site and no suitable related bone marrow treatment (BMT) donor is available

Participant type(s)

Patient

Age group

Not Specified

Sex

Not Specified

Target number of participants

200 - Closed to recruitment - in long term follow-up

Participant exclusion criteria

1. They are multiply relapsed patients
2. They have a prior history of toxicity or organ damage such that completion of the protocol is felt unlikely at the outset
3. They have had an isolated CNS or testicular relapse more than 6 months off treatment.

Recruitment start date

01/02/1995

Recruitment end date

30/09/2008

Locations

Countries of recruitment

England, United Kingdom

Study participating centre

The Children's Hospital
Birmingham
B16 8ET
United Kingdom

Sponsor information

Organisation

Medical Research Council (MRC) (UK)

Sponsor details

20 Park Crescent
London
W1B 1AL
United Kingdom
+44 (0)20 7636 5422
clinical.trial@headoffice.mrc.ac.uk

Sponsor type

Research council

Website

http://www.mrc.ac.uk

Funders

Funder type

Research council

Funder name

UK Medical Research Council

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/07/2005 Yes No

Additional files

Editorial Notes